More than 60 experts will define the future of rare diseases on 4 November at the Foresight 2030 conference, an event framed within the European Rare 2030 project to define the roadmap to be followed in Spain and throughout Europe in this field. AELMHU has offered its support for the development of the event, which will take place online, and will be represented at the meeting sessions by its President, Jorge Capapey, and its Executive Director, Marian Corral.
Rare2030 is a study led by the European Rare Disease Alliance (EURORDIS) that brings together all stakeholders involved in addressing these pathologies to establish policy recommendations for the future. Specifically, the meeting will address integrated care, personalised medicine, European Reference Networks, pharmacotherapeutic treatments and post-COVID healthcare.
